117 related articles for article (PubMed ID: 3283227)
1. Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.
Waeber G; Beck G; Waeber B; Bidiville J; Nussberger J; Brunner HR
J Hypertens; 1988 Mar; 6(3):239-45. PubMed ID: 3283227
[TBL] [Abstract][Full Text] [Related]
2. Trials using a crossover design and ambulatory blood pressure recordings to determine the efficacy of antihypertensive agents in individual patients.
Waeber B; Burnier M; Nussberger J; Brunner HR
J Hypertens Suppl; 1990 Sep; 8(4):S37-41. PubMed ID: 2258782
[TBL] [Abstract][Full Text] [Related]
3. Ambulatory blood pressure measurement and antihypertensive therapy.
Waeber B; Burnier M; Perret F; Nussberger J; Brunner HR
J Hypertens Suppl; 1989 May; 7(3):S33-9. PubMed ID: 2668463
[TBL] [Abstract][Full Text] [Related]
4. A comparison of betaxolol and nadolol on renal function in essential hypertension.
Bauer JH; Reams GP; Lau A
Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292
[TBL] [Abstract][Full Text] [Related]
5. Comparison of two doses of betaxolol and placebo in hypertension: a randomized, double-blind cross-over trial.
Salonen JT; Palminteri R
Eur J Clin Pharmacol; 1982; 23(6):491-4. PubMed ID: 6761136
[TBL] [Abstract][Full Text] [Related]
6. Unpredictability of blood pressures recorded outside the clinic in the treated hypertensive patient.
Porchet M; Bussien JP; Waeber B; Nussberger J; Brunner HR
J Cardiovasc Pharmacol; 1986; 8(2):332-5. PubMed ID: 2422472
[TBL] [Abstract][Full Text] [Related]
7. Casual versus 24-hour ambulatory blood pressure recording in the evaluation of chronic administration of sustained-release verapamil.
Cardillo C; Savi L; Musumeci V; Mores N; Mettimano M; Costalunga A; Guerrera G; Melina D; Folli G
J Hum Hypertens; 1988 Mar; 1(4):281-5. PubMed ID: 3221375
[TBL] [Abstract][Full Text] [Related]
8. [Comparative pharmacoclinical study of 2 beta-blockers: atenolol and betaxolol in slight-to-moderate arterial hypertension].
Herpin D; Boutaud P; Ciber MA; Amiel A; Demange J
Ann Cardiol Angeiol (Paris); 1987 Nov; 36(9):487-93. PubMed ID: 2892458
[TBL] [Abstract][Full Text] [Related]
9. Sustained release verapamil in hypertension. Results from a noninvasive ambulatory blood pressure monitoring and a clinical study.
Nissinen A; Koistinen A; Tuomilehto J; Sundberg S; Gordin A
Eur J Clin Pharmacol; 1986; 31(3):255-9. PubMed ID: 3539623
[TBL] [Abstract][Full Text] [Related]
10. The efficacy and duration of action of sustained-release verapamil in essential hypertension.
McCormack PM; Latham AN; Mee F; Atkins N; O'Brien ET; O'Malley K
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S34-7. PubMed ID: 2475682
[TBL] [Abstract][Full Text] [Related]
11. The acute and chronic effects of betaxolol on blood pressure, renin-aldosterone, and renal function in essential hypertension.
Reams GP; Bauer JH; Lau A
J Clin Pharmacol; 1987 Feb; 27(2):118-21. PubMed ID: 2890665
[TBL] [Abstract][Full Text] [Related]
12. Verapamil and 24-hour ambulatory blood pressure monitoring in essential hypertension.
Zachariah PK; Sheps SG; Schirger A; Spiekerman RE; O'Brien PC; Simpson KK
Am J Cardiol; 1986 Feb; 57(7):74D-79D. PubMed ID: 3953429
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness.
Novo S; Alaimo G; Abrignani MG; Longo B; Muratore G; Strano A
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S38-41. PubMed ID: 2475683
[TBL] [Abstract][Full Text] [Related]
14. Effects of sustained-release verapamil on 24-hour ambulatory blood pressure and on pressor response to isometric exertion in hypertensive patients.
Cardillo C; Musumeci V; Mores N; Folli G
J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S31-3. PubMed ID: 2475681
[TBL] [Abstract][Full Text] [Related]
15. Shortcomings of office blood pressures in assessing antihypertensive therapy.
Waeber B; Nussberger J; Brunner HR
Clin Exp Hypertens A; 1985; 7(2-3):291-8. PubMed ID: 4006240
[TBL] [Abstract][Full Text] [Related]
16. Ambulatory blood pressure recordings. Reproducibility and unpredictability.
des Combes BJ; Porchet M; Waeber B; Brunner HR
Hypertension; 1984; 6(3):C110-5. PubMed ID: 6735450
[TBL] [Abstract][Full Text] [Related]
17. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
[TBL] [Abstract][Full Text] [Related]
18. Effect of verapamil on home self-measurement of blood pressure and heart rate by hypertensive patients. Verapamil-Frequency Research Group.
Fernández-González R; Gómez-Pajuelo C; Gabriel R; de La Figuera M; Moreno E; of The Verapamil-Frequency Res
Blood Press Monit; 2000 Feb; 5(1):23-30. PubMed ID: 10804447
[TBL] [Abstract][Full Text] [Related]
19. The antihypertensive efficacy of verapamil in the elderly evaluated by ambulatory blood pressure measurement.
Cox JP; O'Boyle CA; Mee F; Kelly J; Atkins N; Coakley D; O'Brien ET; O'Malley K
J Hum Hypertens; 1988 Jun; 2(1):41-7. PubMed ID: 3070032
[TBL] [Abstract][Full Text] [Related]
20. Twice-daily verapamil for hypertension: a comparison with propranolol.
Hornung RS; Jones RI; Gould BA; Sonecha T; Raftery EB
Am J Cardiol; 1986 Feb; 57(7):93D-98D. PubMed ID: 3513519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
